M. Arshad Siddiqui

Beijing University of Chemical Technology — China

Medicine · Health Sciences

30h-index3.1kcitations142works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(30), Chemical Synthesis and Analysis(29), DNA and Nucleic Acid Chemistry(18), Biochemical and Molecular Research(16), HIV Research and Treatment(14)

Publications142 total

Two‐Dimensional Materials‐Based Heterogeneous Thermo‐Catalysis: Results, Challenges, and Outlook
Carbon and Hydrogen·2025· 1 citedOpen Access
Contrasting Behavior of Conformationally Locked Carbocyclic Nucleosides of Adenosine and Cytidine as Substrates for Deaminases
UNC Libraries·2020Open Access
Glycoamino Acid Analogues of the Thomsen–Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides
ACS Omega·2017· 8 citedOpen Access
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors
Bioorganic & Medicinal Chemistry Letters·2017· 9 citedOpen Access
Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors
Bioorganic & Medicinal Chemistry·2015· 15 citedOpen Access
ChemInform Abstract: Acid‐Mediated Cyclizations of SEM‐Protected Heterocyclic Anilines and Adjacent Hydroxyls of Enol‐Ethers.
ChemInform·2014
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor
Bioorganic & Medicinal Chemistry Letters·2013· 24 citedOpen Access
Acid-mediated cyclizations of SEM-protected heterocyclic anilines and adjacent hydroxyls or enol-ethers
Tetrahedron Letters·2013· 4 cited
Recognition of the Thomsen-Friedenreich Pancarcinoma Carbohydrate Antigen by a Lamprey Variable Lymphocyte Receptor
Journal of Biological Chemistry·2013· 44 citedOpen Access
Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors
Bioorganic & Medicinal Chemistry Letters·2013· 10 citedOpen Access
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors
Bioorganic & Medicinal Chemistry Letters·2013· 35 citedOpen Access
Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity
Bioorganic & Medicinal Chemistry Letters·2012· 11 citedOpen Access
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors
Bioorganic & Medicinal Chemistry Letters·2011· 37 citedOpen Access
A Direct, Efficient Method for the Preparation of siRNAs Containing Ribo-like <i>North</i> Bicyclo[3.1.0]hexane Pseudosugars
Organic Letters·2011· 12 citedOpen Access
Abstract 1945: Inhibition of PTK6 kinase activity reduces proliferation and migration of tumor cells
Cancer Research·2011
ChemInform Abstract: Design, Synthesis and SAR of Thienopyridines as Potent CHK1 Inhibitors.
ChemInform·2011
4′-<i>C</i>-Methyl-2′-Deoxyadenosine and 4′-<i>C</i>-Ethyl-2′-Deoxyadenosine Inhibit HIV-1 Replication
Antimicrobial Agents and Chemotherapy·2011· 8 citedOpen Access
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors
Bioorganic & Medicinal Chemistry Letters·2011· 27 citedOpen Access
CCDC 739340: Experimental Crystal Structure Determination
The Cambridge Structural Database·2011Open Access
Design and synthesis of potent Gram-negative specific LpxC inhibitors
Bioorganic & Medicinal Chemistry Letters·2010· 44 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Víctor E. Márquez(21), Joseph J. Barchi(9), Harry Ford(7), Janeta Popovici-Müller(7), Pamela Russ(6), Clifford George(6), Peter Orth(6), K Rösner(6), Gerald W. Shipps(6), Patrick J. Curran(6), Victor Snieckus(5), Hiroaki Mitsuya(5), Marc C. Nicklaus(5), Zhuyan Guo(5), Chaoyang Dai(5), Joseph A. Kozlowski(5), Brian J. Lavey(5), Dansu Li(5), Daniel Lundell(5), Xiaoda Niu(5)